A new compound which reversibly arrests T lymphocyte cell cycle near the G1/S boundary.
A novel cell cycle blocking agent profoundly suppressed the proliferation of mitogen-stimulated T lymphocytes. The carboxythiazole derivative arrested cells in the G1 phase of the cell cycle but did not inhibit the induction of cell surface receptors for either interleukin-2 or transferrin. The uncoupling of transferrin receptor expression from DNA synthesis indicated that a previously undefined restriction point in the cell cycle has been identified which occurs after transferrin receptor expression in late G1 and just prior to the initiation of DNA replication in S phase. T cells incubated in an inhibitory dose of the carboxythiazole derivative resumed cell cycle progression subsequent to its removal, indicating that the compound reversibly arrests cells at the late G1 restriction point. In contrast to other techniques which have been inefficient in achieving T cell synchronization, T cells released from the block mediated by the carboxythiazole compound progress through S phase with a considerable degree of synchrony.
Lalande
M
M
Howard Hughes Medical Institute, Division of Genetics, Boston, Massachusetts.
Hanauske-Abel
H M
HM
D002453:Cell Cycle / Q000187:drug effects / Q000502:physiology; D002455:Cell Division / Q000187:drug effects; D002478:Cells, Cultured; D005786:Gene Expression Regulation / Q000187:drug effects / Q000502:physiology; D006801:Humans; D007399:Interphase / Q000187:drug effects* / Q000502:physiology; D008213:Lymphocyte Activation / Q000187:drug effects; D015375:Receptors, Interleukin-2 / Q000235:genetics; D011990:Receptors, Transferrin / Q000235:genetics; D013601:T-Lymphocytes / Q000166:cytology* / Q000502:physiology / Q000648:ultrastructure; D013844:Thiazoles / Q000494:pharmacology*
D015375:Receptors, Interleukin-2; D011990:Receptors, Transferrin; D013844:Thiazoles; C063742:HOE 768159